Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Surg Oncol. 2020 May 27;122(3):422–432. doi: 10.1002/jso.25984

TABLE 1.

Characteristics of gastric cancer patients undergoing curative-intent gastrectomy after preoperative chemotherapy and CXRT stratified according to TRG.

n (%)
Characteristic All (n = 247) TRG
0 (n = 52) 1 (n = 49) 2 (n = 98) 3 (n = 48) P value
Age 0.205
<65 years 159 (64.4) 28 (53.8) 33 (67.3) 69 (70.4) 29 (60.4)
≥65 years 88 (35.6) 24 (46.2) 16 (32.7) 29 (29.6) 19 (39.6)
Sex 0.041
Male 147 (59.5) 37 (71.2) 34 (69.4) 51 (52.0) 25 (52.1)
Female 100 (40.5) 15 (28.9) 15 (30.6) 47 (48.0) 23 (47.9)
Race/ethnicity 0.543
White 137 (55.5) 31 (59.6) 30 (61.2) 53 (54.1) 23 (47.9)
Black 22 (8.9) 3 (5.8) 5 (10.2) 9 (9.2) 5 (10.4)
Asian 61 (24.7) 13 (25.0) 10 (20.4) 21 (21.4) 17 (35.4)
 Hispanic/Latino 27 (10.9) 5 (9.6) 4 (8.2) 15 (15.3) 3 (6.3)
Tumor histology 0.710
Moderately differentiated 52 (21.1) 13 (25.0) 9 (18.4) 22 (22.5) 8 (16.7)
Poorly differentiated 175 (70.9) 33 (63.5) 35 (71.4) 71 (72.5) 36 (75.0)
Unknown 20 (8.1) 6 (11.5) 5 (10.2) 5 (5.1) 4 (8.3)
Signet ring cell features <0.001
No 126 (51.0) 42 (80.8) 25 (51.0) 43 (43.9) 16 (33.3)
Yes 121 (49.0) 10 (19.2) 24 (49.0) 55 (56.1) 32 (66.7)
Linitis plastica 0.150
No 223 (90.3) 50 (96.2) 43 (87.8) 90 (91.8) 40 (83.3)
Yes/suspected 24 (9.7) 2 (3.9) 6 (12.2) 8 (8.2) 8 (16.7)
Tumor location 0.030
Gastroesophageal junction 67 (27.1) 16 (30.8) 19 (38.8) 26 (26.5) 6 (12.5)
Cardia/fundus 18 (7.3) 4 (7.7) 3 (6.1) 9 (9.2) 2 (4.2)
Body 101 (40.9) 18 (34.6) 14 (28.6) 43 (43.9) 26 (54.2)
Distal 50 (20.2) 14 (26.9) 9 (18.4) 18 (18.4) 9 (18.8)
Total 11 (4.5) 0 (0.0) 4 (8.2) 2 (2.0) 5 (10.4)
Margin status 0.213a
R0 229 (92.7) 52 (100.0) 44 (89.8) 92 (93.9) 41 (85.4)
R1 18 (7.3) 0 (0.0) 5 (10.2) 6 (6.1) 7 (14.6)
Postoperative chemotherapy 0.148
No 238 (96.4) 51 (98.1) 48 (98.0) 91 (92.9) 48 (100.0)
Yes 9 (3.6) 1 (1.9) 1 (2.0) 7 (7.1) 0 (0.0)
Organ resection 0.129
No 207 (83.8) 44 (84.6) 45 (91.8) 76 (77.6) 42 (87.5)
Yes 40 (16.2) 8 (15.4) 4 (8.2) 22 (22.5) 6 (12.5)
Extent of lymph node dissection 0.442
D0/D1 28 (11.3) 8 (15.4) 7 (14.3) 6 (6.1) 7 (14.6)
D1+/D2 218 (88.3) 44 (84.6) 42 (85.7) 91 (92.9) 41 (85.4)
Unknown 1 (0.4) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0)
Number of lymph nodes examined 0.026
<16 68 (27.5) 17 (32.7) 19 (38.8) 17 (17.4) 15 (31.3)
≥16 179 (72.5) 35 (67.3) 30 (61.2) 81 (82.7) 33 (68.8)
cT category 0.714
1 1 (0.4) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0)
2 30 (12.2) 5 (9.6) 9 (18.4) 9 (9.2) 7 (14.6
3/4a 193 (78.1) 41 (78.9) 38 (77.6 78 (79.6) 36 (75.0)
4b 23 (9.3) 6 (11.5) 2 (4.1) 10 (10.2) 5 (10.4)
cN status 0.492
Negative 106 (42.9) 19 (36.5) 23 (46.9) 46 (46.9) 18 (37.5)
Positive 141 (57.1) 33 (63.5) 26 (53.1) 52 (53.1) 30 (62.5)
ypT category <0.001
0 52 (21.1) 52 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
1a/1b 40 (16.2) 0 (0.0) 18 (36.7) 19 (19.4) 3 (6.3)
2 48 (19.4) 0 (0.0) 14 (28.6) 24 (24.5) 10 (20.8)
3 85 (34.4) 0 (0.0) 16 (32.7) 44 (44.9) 25 (52.1)
4a/4b 22 (8.9) 0 (0.0) 1 (2.0) 11 (11.2) 10 (20.8)
ypN status <0.001
ypN- 161 (65.2) 46 (88.5) 34 (69.4) 63 (64.3) 18 (37.5)
ypN+ 86 (34.8) 6 (11.5) 15 (30.6) 35 (35.7) 30 (62.5)
LR 0.892
No 232 (93.9) 52 (100.0) 46 (93.9) 90 (91.8) 44 (91.7)
Yes 15 (6.1) 0 (0.0) 3 (6.1) 8 (8.2) 4 (8.3)
DR 0.057
No 168 (68.0) 42 (80.8) 35 (71.4) 64 (65.3) 27 (56.3)
Yes 79 (32.0) 10 (19.2) 14 (28.6) 34 (34.7) 21 (43.8)
Vital status 0.418
Alive 131 (53.0) 27 (51.9) 24 (49.0) 58 (59.2) 22 (45.8)
Dead 116 (47.0) 25 (48.1) 25 (51.0) 40 (40.8) 26 (54.2)
Type of resection 0.233
Total gastrectomy 140 (56.7) 26 (50.0) 31 (63.3) 52 (53.1) 31 (64.6)
Subtotal gastrectomy 93 (37.7) 22 (42.3) 13 (26.5) 42 (42.9) 16 (33.3)
Proximal gastrectomy 14 (5.7) 4 (7.7) 5 (10.2) 4 (4.1) 1 (2.1)